Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

Presentation CDM 2018

The Hope and Promise of Renal Denervation

Presenter: Michael A.Weber

October 12, 2018

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

Presentation TCT Abstracts Posters 2018

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Presenter: Tamon Kato

September 25, 2018

News Conference News TCT 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Todd Neale

September 25, 2018

Presentation TCT 2018

Topic 6: Radial Access and AKI- What Do We Know?

Presenter: Sripal Bangalore, Somjot S. Brar

September 23, 2018

Presentation TCT 2018

Topic 5: CIN Prevention Strategies

Presenter: Sripal Bangalore, Somjot S. Brar, Roxana Mehran

September 23, 2018

Presentation TCT 2018

Topic 4: CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore, Somjot S. Brar, Hitinder S. Gurm

September 23, 2018

Presentation TCT 2018

Topic 3: Revascularization Strategies (PCI, CABG) vs Medical Therapy in Advanced CKD

Presenter: Sripal Bangalore, Somjot S. Brar

September 23, 2018

Presentation TCT 2018

Topic 2: Zero Contrast PCI

Presenter: Sripal Bangalore, Somjot S. Brar, Ziad A. Ali

September 23, 2018

Presentation TCT 2018

Topic 1: Prognostic Significance of Acute Kidney Injury After TAVR

Presenter: Sripal Bangalore, Somjot S. Brar, Steven R. Bailey

September 23, 2018

Presentation TCT 2018

Thailand Presents: Percutaneous Closure of a High-Flow Acquired Renal AV Fistula Using AVP2 in a Patient With Heart Failure and Pulmonary Hypertension

Presenter: Yutaka Hikichi, Teguh Santoso, Hsuan-Li Huang, Wirash Kehasukcharoen, Wen-Lieng Lee, Samuel Sudanawidjaja, Damras Tresukosol

September 23, 2018

Presentation TCT 2018

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Hiren Mistry

September 22, 2018

Presentation TCT 2018

Japanese Perspective and Experience on RDN Studies

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno

September 22, 2018

Presentation TCT 2018

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Justin E. Davies

September 22, 2018

Presentation TCT 2018

ISR and Complex Anatomy in Renal Stenting

Presenter: Sahil A. Parikh, Virendra I Patel, Mark C. Bates

September 21, 2018

Presentation TCT 2018

Renal Denervation: Light on the Horizon?

Presenter: Jeroen J. Bax, Stephan Windecker, Felix Mahfoud

September 21, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

News Industry News

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

April 26, 2018

Presentation JIM 2018

Vascular Complications

Presenter: Bernhard Reimers

February 23, 2018

Advertisement

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

The Hope and Promise of Renal Denervation

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Topic 6: Radial Access and AKI- What Do We Know?

Topic 5: CIN Prevention Strategies

Topic 4: CIN Risk Prediction and Outcomes

Topic 3: Revascularization Strategies (PCI, CABG) vs Medical Therapy in Advanced CKD

Topic 2: Zero Contrast PCI

Topic 1: Prognostic Significance of Acute Kidney Injury After TAVR

Thailand Presents: Percutaneous Closure of a High-Flow Acquired Renal AV Fistula Using AVP2 in a Patient With Heart Failure and Pulmonary Hypertension

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Japanese Perspective and Experience on RDN Studies

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

ISR and Complex Anatomy in Renal Stenting

Renal Denervation: Light on the Horizon?

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

Vascular Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content